Analysts Estimate Report : What to Look Out for UnitedHealth Group (NYSE:UNH)

Earnings results for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Incorporated is expected* to report earnings on 10/14/2021 before market open. The report will be for the fiscal Quarter ending Sep 2021. According to Zacks Investment Research, based on 10 analysts’ forecasts, the consensus EPS forecast for the quarter is $4.41. The reported EPS for the same quarter last year was $3.51.

UnitedHealth Group last announced its earnings results on July 14th, 2021. The healthcare conglomerate reported $4.70 EPS for the quarter, beating the consensus estimate of $4.43 by $0.27. The firm earned $71.32 billion during the quarter, compared to analysts’ expectations of $69.51 billion. Its quarterly revenue was up 14.8% compared to the same quarter last year. UnitedHealth Group has generated $16.88 earnings per share over the last year ($15.14 diluted earnings per share) and currently has a price-to-earnings ratio of 26.6. Earnings for UnitedHealth Group are expected to grow by 15.85% in the coming year, from $18.74 to $21.71 per share. UnitedHealth Group has confirmed that its next quarterly earnings report will be published on Thursday, October 14th, 2021. UnitedHealth Group will be holding an earnings conference call on Thursday, October 14th at 8:45 AM Eastern. Interested parties can or dial in at 888-203-1112 with passcode “5065077”.

Analyst Opinion on UnitedHealth Group (NYSE:UNH)

According to the issued ratings of 24 analysts in the last year, the consensus rating for UnitedHealth Group stock is Buy based on the current 3 hold ratings, 20 buy ratings and 1 strong buy rating for UNH. The average twelve-month price target for UnitedHealth Group is $447.79 with a high price target of $522.00 and a low price target of $330.00.

on UNH’s analyst rating history

UnitedHealth Group has received a consensus rating of Buy. The company’s average rating score is 2.92, and is based on 20 buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $447.79, UnitedHealth Group has a forecasted upside of 11.0% from its current price of $403.24. UnitedHealth Group has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Dividend Strength: UnitedHealth Group (NYSE:UNH)

UnitedHealth Group pays a meaningful dividend of 1.43%, higher than the bottom 25% of all stocks that pay dividends. UnitedHealth Group has only been increasing its dividend for 1 years. The dividend payout ratio of UnitedHealth Group is 34.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 26.72% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.

Insiders buying/selling: UnitedHealth Group (NYSE:UNH)

In the past three months, UnitedHealth Group insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $42,396,929.00 in company stock. Only 0.55% of the stock of UnitedHealth Group is held by insiders. 86.21% of the stock of UnitedHealth Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of UnitedHealth Group (NYSE:UNH

Earnings for UnitedHealth Group are expected to grow by 15.85% in the coming year, from $18.74 to $21.71 per share. The P/E ratio of UnitedHealth Group is 26.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.76. The P/E ratio of UnitedHealth Group is 26.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 32.61. UnitedHealth Group has a PEG Ratio of 1.62. PEG Ratios above 1 indicate that a company could be overvalued. UnitedHealth Group has a P/B Ratio of 5.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here